Flagfer Injection contains Iron Sucrose (100mg) and is primarily used to treat iron deficiency anemia, especially in patients with chronic kidney disease or those who cannot tolerate oral iron supplements. Iron is an essential mineral required for the production of hemoglobin, which carries oxygen in the blood. This injectable formulation allows for rapid replenishment of iron stores, improving hemoglobin levels and alleviating symptoms such as fatigue, weakness, and pallor associated with anemia. Flagfer Injection is administered intravenously under medical supervision, ensuring controlled and effective delivery of iron directly into the bloodstream. It is particularly beneficial for patients undergoing hemodialysis or those with malabsorption issues that limit oral iron uptake. Common side effects may include mild pain or irritation at the injection site, dizziness, or nausea, but serious adverse reactions are rare when used appropriately. Before administration, patients should be evaluated for iron overload conditions and allergies to iron preparations. Regular monitoring of hemoglobin and iron levels is recommended to avoid complications. Flagfer Injection offers a reliable and efficient option for managing iron deficiency anemia, improving patient quality of life by restoring adequate iron levels and supporting overall hematologic health.